Paul Bartel, PhD

Director, PharmaDx Program
Dr. Bartel is an adjunct assistant professor at the University of Utah School of Medicine. His role at ARUP as the director of the PharmaDx program involves developing and managing collaborations with pharmaceutical companies. The PharmaDx team has considerable experience in the development of companion diagnostic tests and has received FDA approval for two tests developed and validated for use with the drug Gleevec. Before joining ARUP, Dr. Bartel held various positions at Myriad Genetics, Myriad Pharmaceuticals, and the Moran Eye Center at the University of Utah. Dr. Bartel received an MS in chemical engineering and a PhD in molecular microbiology from the Ohio State University. Dr. Bartel trained as a postdoctoral fellow at the State University of New York at Stony Brook, where he helped develop the yeast two-hybrid system to detect protein-protein interactions.